Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00024123
DRKS00024123
Completed
N/A

Prospective observational study on the clinical relevance of the combined PET / MR examination in pediatric oncology - GK-PET/MR Tü-013

niversitätsklinikum Tübingen0 sites74 target enrollmentJanuary 19, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC00-C97Malignant neoplasms

Overview

Phase
N/A
Intervention
Not specified
Conditions
C00-C97
Sponsor
niversitätsklinikum Tübingen
Enrollment
74
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 19, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Tübingen

Eligibility Criteria

Inclusion Criteria

  • •Children or adolescents \<18 years of age for whom the PET/MRI examination is carried out for the following indications:
  • •PET/MRI examination for clinical indication for tumor search (e.g. FUO)
  • •PET/MRI examination for clinical indication for primary staging or re\-staging in Hodgin's lymphoma
  • •PET/MRI examination for clinical indication for primary staging or re\-staging after therapy in histologically proven, advanced malignant solid tumors (e.g. bone and soft tissue tumors, CNS tumors, neuroblastomas, germ cell tumors)
  • •PET/MRI examination in the case of unclear or inconspicuous imaging for therapy planning (OP, RT, Ctx) and prognosis stratification
  • •PET/MRI examination for re\-staging in neurofibromatosis type I with the question of a malignant transformation of the neurofibromas and for biopsy or surgery planning
  • •Written consent of the legal guardian and, if applicable, the child (depending on the individual stage of development) to participate in the study and to report so\-called incidental findings after detailed explanation

Exclusion Criteria

  • •Presence of non\-MRI\-compatible implants or any kind of metal in and on the body (e.g. pacemakers, artificial heart valves, metal prostheses, implanted, magnetic metal parts, coils, etc.)
  • •Children and adolescents who report a hearing disorder or an increased sensitivity to loud noises
  • •Children and adolescents with reduced temperature sensation and/or increased sensitivity to warming of the body
  • •pregnancy
  • •Diabetes mellitus that cannot be controlled with medication

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Prospective observational study on the clinical course and treatment effect based on QOL evaluation in seasonal influenza
JPRN-UMIN000034896Department of Internal Medicine, Teikyo University School of Medicine55
Not Yet Recruiting
N/A
ROLE OF HOMOEOPATHIC MEDICINE IN DIABETES MELLITUS 2Health Condition 1: E11- Type 2 diabetes mellitus
CTRI/2022/01/039691SUNIL THUMAR
Completed
N/A
Observational prospective study to evaluate clinical significance of endothelial vasomotor function in the culprit coronary artery in patients with acute myocardial infarctioAcute myocardial infarction
JPRN-UMIN000018434niversity of Yamanashi, Department of Internal Medicine II200
Completed
N/A
Observational prospective study to evaluate clinical significance of statin therapy after percutaneous coronary intervention in patients aged 75 years and above.Coronary artery disease
JPRN-UMIN000044531niversity of Yamanashi, Department of Internal Medicine II1,607
Not Yet Recruiting
N/A
To Study Clinical Characteristics, Treatment Outcome of Coronavirus (COVID-19) PatientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/05/025247Dr Amit Patel